| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/02/2009 | US20090087407 Methods for the treatment of scleroderma using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline |
| 04/02/2009 | DE112007001091T5 Pharmazeutische Formulierung in Form einer Salbe für die Behandlung von Tinea der Füße und Hände und Zubereitungsverfahren davon Pharmaceutical formulation in the form of an ointment for the treatment of tinea of the feet and hands, and preparation method thereof |
| 04/02/2009 | DE102007046600A1 Verfahren zum Applizieren eines flüssigen, medizinischen Behandlungsmediums auf einen zu behandelden Bereich sowie Medizinprodukt A method of applying a liquid medium to a medical treatment to the area treated are and medical device |
| 04/02/2009 | DE102007045476A1 Neue heteroarylsubstituierte Acetonderivate, geeignet zur Hemmung der Phospholipase A2 New heteroaryl acetone derivatives useful for inhibiting phospholipase A2 |
| 04/02/2009 | CA2700601A1 Use of a monoterpene to increase tissue repair |
| 04/02/2009 | CA2700365A1 Benzoquinone derivative e3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesis |
| 04/02/2009 | CA2700274A1 Quinone derivatives, pharmaceutical compositions, and uses thereof |
| 04/01/2009 | EP2042518A2 Dual specificity antibodies and methods of making and using |
| 04/01/2009 | EP2042510A2 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleid acid (siNA) |
| 04/01/2009 | EP2042500A1 N-[4-(1-H-pyrazolo[3,4-c]pyridin-4-yl)phenyl]-N'-[(hetero)aryl]-urea compounds, pharmaceutical compositions comprising them, their preparation and their use as Tie2-kinase inhibitors |
| 04/01/2009 | EP2042499A1 Salt of morpholine compound |
| 04/01/2009 | EP2042173A2 Kappa-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative |
| 04/01/2009 | EP2042171A1 Therapeutic or prophylactic agent for allergic dermatitis |
| 04/01/2009 | EP2042168A1 Inhalation device comprising phenethanolamine derivatives for treatment of respiratory diseases |
| 04/01/2009 | EP2042167A1 Use of a monoterpene to induce tissue repair |
| 04/01/2009 | EP2042157A1 Hair growth composition |
| 04/01/2009 | EP2041135A1 8-oxoadenine derivatives acting as modulators of tlr7 |
| 04/01/2009 | EP2041095A1 Novel tyrosinase inhibitors, their process of preparation and their use in human medicine and in cosmetics |
| 04/01/2009 | EP2040754A1 Use of adipose-tissue cell fractions for post-irradiation tissue regeneration |
| 04/01/2009 | EP2040696A2 Compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders |
| 04/01/2009 | EP2040693A2 Transdermal delivery of oleocanthal for relief of inflammation |
| 04/01/2009 | EP2040669A1 Wound care treatment product |
| 04/01/2009 | EP1824515B1 Treatment of dermatitis with dehydroepiandrosterone-glucocorticoid combinations |
| 04/01/2009 | EP1450804B9 Pharmaceutical formulations comprising an immune response modifier |
| 04/01/2009 | EP1349873B1 Modulation of il-2- and il-15-mediated t cell responses |
| 04/01/2009 | CN101400338A Pharmaceutical composition of microspheres for preventing diabetic foot amputation |
| 04/01/2009 | CN101400333A Skin-whitening agent for external application to the skin, and method for whitening the skin |
| 04/01/2009 | CN101396507A Traditional Chinese medicine antibacterial liquid and preparation method and use thereof |
| 04/01/2009 | CN101396496A Medicine for treating trauma and ulcer |
| 04/01/2009 | CN101396491A Manufacture method of expressed juice capable of eliminating general itch for five minutes |
| 04/01/2009 | CN101396463A Chinese herbal medicine external liniment for treating beriberi |
| 04/01/2009 | CN101396454A Traditional Chinese medicine for treating diabetic skin pruritus |
| 04/01/2009 | CN101396440A Preparation method of skin tinea treating medicine |
| 04/01/2009 | CN101396385A Manufacture method of quick sweat-stain removing paste |
| 04/01/2009 | CN101396384A Asiatic centella extract and preparation methode thereof |
| 04/01/2009 | CN101396376A Manufacture method of paste capable of quickly treating red and white flux |
| 04/01/2009 | CN101396375A Manufacture method of paste capable of quickly treating itchy anus |
| 04/01/2009 | CN101396374A Preparation method of spiral collagen freeze-dry powder prepared by extracting deep-sea cod fish-skin |
| 04/01/2009 | CN101396372A Use of C60 polyhydroxy derivates in preventing and treating related disease of mitochondria damage |
| 04/01/2009 | CN101396363A Composite antibacterial drugs composition containing abafungin |
| 04/01/2009 | CN100473417C Method of modulating memory effector T-cells using CD2-binding agent, and compositions |
| 04/01/2009 | CN100473387C Calf serum de-protein injection and producing method thereof |
| 04/01/2009 | CN100473384C Pharmaceutical formulations comprising an immune response modifier |
| 04/01/2009 | CN100473380C Medicine for treating tinea pedis |
| 03/31/2009 | US7511144 Reverse hydroxamic acid derivatives |
| 03/31/2009 | US7511121 Polymeric immunoglobulin fusion proteins that target low-affinity Fcγreceptors |
| 03/31/2009 | US7511061 Triazoles as farnesyl transferase inhibitors |
| 03/31/2009 | US7511047 Kinase inhibitors |
| 03/31/2009 | US7511010 Pharmaceutical or cosmetic composition and use of a PKC inhibitor with an MMP inhibitor for inhibiting Langerhans' cell migration |
| 03/31/2009 | US7510853 Exhibiting similarity to cytokine; isolated or recombinant polynucleotide encoding antigenic polypeptide of sequence 2 |
| 03/31/2009 | US7510843 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease |
| 03/31/2009 | US7510825 Detecting perturbations and alterations of the normal organization of the cell plasma membrane (PNOM)-cells within a population of cells using a "perturbed membrane-binding compound" (PMBC) of given formula; e.g. monitoring aggressiveness of a tumor |
| 03/31/2009 | US7510711 Nucleotide sequence coding monoclonal antibody; anticancer agents; antiinflammatory agents; immunology disorders |
| 03/31/2009 | CA2466654C Compositions comprising chitosan in the form of nano-sized fibres |
| 03/31/2009 | CA2417897C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 03/31/2009 | CA2328368C Anti-inflammatory agents |
| 03/31/2009 | CA2292549C Use of colchinol derivatives as vascular damaging agents |
| 03/26/2009 | WO2009038057A1 Nitrogenated fused-ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
| 03/26/2009 | WO2009037855A1 Oral and skin compositions |
| 03/26/2009 | WO2009036771A1 Composition comprising mucilaginous polysaccharides derived from aloe barbadensis combined with liposomes, method for obtaining same and use thereof as a sun protector, an anti-acne agent, an epidermal regenerator and a moisturiser |
| 03/26/2009 | WO2009036751A2 Cosmetic or dermatological composition for topical application |
| 03/26/2009 | WO2009036714A1 Composition for the treatment of wounds, containing at least silver and urea |
| 03/26/2009 | WO2009013433A3 Use of pactimibe for the preparation of a drug intended to prevent or treat a disease caused by a sebaceous gland dysfunction in humans or animals |
| 03/26/2009 | WO2009001209A8 Use of conjugates of hyaluronic acid in the local treatment of hyperproliferative skin diseases |
| 03/26/2009 | WO2008116641A3 Oleyl phosphocholine |
| 03/26/2009 | US20090082567 2,4-pyrimidinediamine compounds and their uses |
| 03/26/2009 | US20090082451 Use of thyroid hormone conversion inhibitors |
| 03/26/2009 | US20090082386 Ascomycin and pimecrolimus having reduced levels of desmethylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof |
| 03/26/2009 | US20090082362 Use of capsaicin receptor antagonists to treat symptoms of tear gas exposure |
| 03/26/2009 | US20090082346 Substituted Pyrrolo-Pyrazole Derivatives as Kinase Inhibitors |
| 03/26/2009 | US20090082345 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors |
| 03/26/2009 | US20090082343 1,3-benzothiazinone derivatives and use thereof |
| 03/26/2009 | US20090082333 Remedy for xanthoma |
| 03/26/2009 | US20090082318 Deuterium-enriched mometasone |
| 03/26/2009 | US20090082317 Low-calcemic 16,23-diene 25-oxime analogs of 1alpha,25-dihydroxy vitamin d3 |
| 03/26/2009 | US20090082292 inhibiting angiogenesis; corneal graft rejection; age related macular degeneration; diabetic retinopathy; dermatological disease |
| 03/26/2009 | US20090082268 Muteins of Placental Growth Factor Type I, Preparation Method And Application Thereof |
| 03/26/2009 | US20090081729 Compositions and Methods Comprising a Ligand of ChemerinR |
| 03/26/2009 | US20090081635 Modified heparinase iii and methods of sequencing therewith |
| 03/26/2009 | US20090081283 Tumor therapy with non-viral-based high affinitiy laminin receptor-targeted vectors |
| 03/26/2009 | US20090081279 Skin Dressings |
| 03/26/2009 | US20090081263 Double-stranded rna oligonucleotides which inhibit tyrosinase expression |
| 03/26/2009 | US20090081242 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 03/26/2009 | US20090081168 Method of forming a peptide-receptor complex with zsig33 |
| 03/26/2009 | US20090081139 Water-based delivery systems |
| 03/26/2009 | US20090081131 Tumor therapy with high affinity laminin receptor-targeted vectors and compounds |
| 03/26/2009 | US20090081126 Novel fully human anti-VAP-1 monoclonal antibodies |
| 03/26/2009 | CA2700335A1 Composition comprising mucilaginous polysaccharides derived from aloe barbadensis combined with liposomes, method for obtaining same and use thereof as a sun protector, an anti-acne agent, an epidermal regenerator and a moisturiser |
| 03/25/2009 | EP2039700A2 Novel anti-inflammatory androstane derivatives |
| 03/25/2009 | EP2039361A2 Use of immunomodulatory compounds |
| 03/25/2009 | EP2039354A1 Compound having activity of blocking nmda receptor channel, and pharmaceutical agent using the same |
| 03/25/2009 | EP2037956A2 Simultaneous, separate or sequential therapeutic use of at least one botulinum neurotoxin and of at least one opiate derivative |
| 03/25/2009 | EP2037950A2 Further medical uses of antisecretory protein |
| 03/25/2009 | EP2037908A2 Method for treatment of wound using aganocides |
| 03/25/2009 | EP2037900A2 Treatment of excess sebum production |
| 03/25/2009 | EP2037742A2 Prevention of nuclear, solar, and other radiation-induced tissue damage |
| 03/25/2009 | EP2000469A9 Acylaminopiperidine compound |
| 03/25/2009 | EP1299421B1 Antibodies to human mcp-1 |
| 03/25/2009 | EP1287035B1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 03/25/2009 | CN101391094A Hair growth and protection medicine |